The pharmacy department supply database was used to generate a summary report of volume of each anti-anginal supplied. This report with prescription audit database was used to determine the relative usage of each anti-anginal by hospitals. Two hospitals were selected and 300 consecutive anti-anginal prescriptions were recorded, analyzed. The interventional study carried out as first audit for 150 prescriptions and after given instruction to clinicians for improvement in quality of prescription writing and rationality the next 150 prescription were collected as second audit.
Supply audit database at selected hospitals suggested that Nitrates, B-blockers, and Ca++ channel blockers were primary line anti-anginal drugs with relative proportional usage from supply data was 29.03%, 58.06%, 12.09% and of prescription audit data was 69.08%, 27.73%, 9.18% respectively. In first audit superscription 86.04%, inscription 54.03% subscription 1.33%, transcription 28.66%, extra point 46.33%, rationality 0.00% were present. The significant improvement as compared to first in second audit was 8.27%, 28.67%, 60.67%, 35.78%, and 14% for superscription, inscription, subscription, transcription, extra point and rationality status respectively. Out of 300 prescriptions 279 prescriptions (93.00%) were irrational based on the use of essential drug WHO and standard treatment guidelines and 207 prescriptions (74.19%) had Aspirin as concomitant drug.
The study result demonstrates that supply data is not an accurate reflection of drug usage particularly in case for drug with multiple indication use like B-blockers. Furthermore, supply data is useful in identifying prescribing trends that can be quantified by prescription audit. The significant improvement has been observed in quality of completeness, legibility rationality after giving training and instructions to clinicians.
Cite this article:
Vishal Chaudhari, Bharati Chaudhari, Avinash Khairnar. A Cross-Sectional Prescription Audit Database for Anti-Anginal Drugs with Impact of Essential Drug List and Standard Treatment Guidelines on Prescription Pattern in Nasik City. Research J. Pharm. and Tech. 4(7): July 2011; Page 1111-1114.